Innate immunity is the first line of defense in the body's immune system, providing rapid and nonspecific protection against a wide range of pathogens. It is an evolutionarily ancient form of immunity that acts immediately upon encountering foreign invaders. Key components of innate immunity include physical barriers like the skin and mucous membranes, as well as cellular components such as phagocytes (like neutrophils and macrophages) and natural killer (NK) cells. These cells are equipped to recognize and eliminate pathogens without the need for prior exposure. Innate immunity also involves the activation of the complement system, a group of proteins that enhance the immune response by promoting inflammation, phagocytosis, and the destruction of pathogens. While innate immunity provides rapid protection, it lacks the specificity and memory characteristic of adaptive immunity. Innate and adaptive immunity work collaboratively, with innate responses initiating the defense against pathogens, and adaptive responses developing over time for more precise and targeted protection. Dysregulation of innate immunity can lead to various diseases, including inflammatory conditions and autoimmune disorders. Understanding the complexities of innate immunity is crucial for developing strategies to modulate the immune system and combat infections and diseases effectively.
Title : A promising novel approach to DNA vaccines
Khursheed Nadeem Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data for a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Evaluating the immunogenic impact of process impurities in mRNA vaccine production: Establishing integrated control strategies and specifications
Jesse Kuiper, Merck Research Laboratories, United States
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Advances in vaccines: Revolutionizing disease prevention
Delia Teresa Sponza, Dokuz Eylul University, Turkey